Publication
2nd Circuit defers to executive will on application of sovereign immunity
The Second Circuit recently held that federal common law protections of sovereign immunity did not preclude prosecution of a state-owned foreign corporation.
United States | Publication | January 18, 2022
In early-December 2021, the Michigan Department of Health and Human Services announced its streamlined guidance to help prevent transmission of COVID among students while reducing disruptions to in-person learning. The Department stated, “[i]n addition to vaccination, which is approved for ages five and up, layered prevention measures, including masking, should be put in place for consistent in-person learning to keep kids, staff and families safe.”
The state recommends that local health departments and the schools “work together to quickly isolate COVID cases among students and staff, identify close contacts of those cases, and adopt quarantine policies that reduce the risk of transmission in schools while allowing in-person learning.” The assumption is that when measures such as vaccination, masking, distancing and testing are utilized, students exposed to COVID may not have to quarantine at home and can stay in the classroom. Universal masking in the K–12 setting remains the recommendation.
Additional guidance for the exposed provides that those who are fully-vaccinated without symptoms do not need to quarantine.
Publication
The Second Circuit recently held that federal common law protections of sovereign immunity did not preclude prosecution of a state-owned foreign corporation.
Publication
Facing the fast-growing development of AI across the globe, particularly Generative AI (GenAI), the G7 competition authorities and policymakers (Canada, France, Germany, Japan, Italy, the UK and the US) and the European Commission met in Italy on 3-4 October 2024 to discuss the main competition challenges raised by these new technologies in digital markets.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023